首页> Anticancer research> Association Between PD-L1 Expression and Efficacy of Chemoimmunotherapy in Extensive-stage Small Cell Lung Cancer.

Association Between PD-L1 Expression and Efficacy of Chemoimmunotherapy in Extensive-stage Small Cell Lung Cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Kenjiro,Tsuruoka

第一单位： Department of Internal Medicine (I), Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan; kenjirou.tsuruoka@ompu.ac.jp.

作者： Kenjiro,Tsuruoka ^[1] ; Yosuke,Tamura ^[2] ; Yasuyuki,Shimazu ^[2] ; Masahiro,Arai ^[2] ; Sho,Mitsuya ^[2] ; Tomoya,Funamoto ^[2] ; Hiroyuki,Tsuji ^[3] ; Ninso,Matsunaga ^[2] ; Takahiko,Nakamura ^[2] ; Soichiro,Ikeda ^[2] ; Shigeru,Kawabata ^[4] ; Akihisa,Imagawa ^[2] ; Yasuhito,Fujisaka ^[5]

作者单位： Department of Internal Medicine (I), Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan; kenjirou.tsuruoka@ompu.ac.jp. ^[1] Department of Internal Medicine (I), Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan. ^[2] Department of Clinical Research Center, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan. ^[3] Department of Pathology, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan. ^[4] Department of Medical Oncology, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan. ^[5]

关键词 Small cell lung cancer immune checkpoint inhibitor (ICI)programmed cell death protein 1 (PD-1)programmed death-ligand 1 (PD-L1)